Clinical data | |
---|---|
Pronunciation | /ˈbjuːspɪroʊn/ (BEW-spi-rohn) |
Trade names | Buspar, Namanspin |
Other names | MJ 9022-1[1] |
AHFS/Drugs.com | Monograph |
MedlinePlus | a688005 |
Pregnancy category |
|
Routes of administration | By mouth |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 3.9%[2] |
Protein binding | 86–95%[3] |
Metabolism | Liver (via CYP3A4)[7][8] |
Metabolites | 5-OH-Buspirone; 6-OH-Buspirone; 8-OH-Buspirone; 1-PP[4][5][6] |
Elimination half-life | 2.5 hours[7] |
Excretion | Urine: 29–63%[3] Feces: 18–38%[3] |
Identifiers | |
| |
Chemical and physical data | |
Formula | C21H31N5O2 |
Molar mass | 385.512 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Buspirone, sold under the brand name Buspar among others, is a medication primarily used to treat anxiety disorders, particularly generalized anxiety disorder.[9][10] Benefits support its short term use.[11] It has not been found to be effective in treating psychosis.[9] It is taken by mouth, and it may take up to four weeks for an effect.[9][10]
Common side effects include nausea, headaches, dizziness, and trouble concentrating.[9][11] Serious side effects may include hallucinations, serotonin syndrome, and seizures.[11] Use in pregnancy appears to be safe but has not been well studied, while use during breastfeeding is not recommended.[11][13] How it works is not clear but it is unrelated to benzodiazepines.[9]
Buspirone was first made in 1968 and approved for medical use in the United States in 1986.[9][10] It is available as a generic medication.[11] A month supply in the United Kingdom costs the NHS about £10 as of 2019.[11] In the United States the wholesale cost of this amount is about US$3.[14] In 2017, it was the 80th most commonly prescribed medication in the United States, with more than ten million prescriptions.[15][16]
References edit
- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 192–. ISBN 978-1-4757-2085-3. Archived from the original on 12 March 2017. Retrieved 11 March 2017.
- ^ Loane C, Politis M (June 2012). "Buspirone: what is it all about?". Brain Research. 1461: 111–8. doi:10.1016/j.brainres.2012.04.032. PMID 22608068.
- ^ a b c "buspirone (Rx) - BuSpar, Buspirex, more." Medscape Reference. WebMD. Archived from the original on 13 July 2019. Retrieved 14 November 2013.
- ^ Gammans RE, Mayol RF, LaBudde JA (March 1986). "Metabolism and disposition of buspirone". The American Journal of Medicine. 80 (3B): 41–51. doi:10.1016/0002-9343(86)90331-1. PMID 3515929.
- ^ Schatzberg, Alan F.; Nemeroff, Charles B. (2009). The American Psychiatric Publishing Textbook of Psychopharmacology. American Psychiatric Pub. pp. 490–. ISBN 978-1-58562-309-9.
- ^ Wong H, Dockens RC, Pajor L, Yeola S, Grace JE, Stark AD, et al. (August 2007). "6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine1A receptor occupancy in rats". Drug Metabolism and Disposition. 35 (8): 1387–92. doi:10.1124/dmd.107.015768. PMID 17494642. S2CID 25558546.
- ^ a b Mahmood I, Sahajwalla C (April 1999). "Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug". Clinical Pharmacokinetics. 36 (4): 277–87. doi:10.2165/00003088-199936040-00003. PMID 10320950. Archived (PDF) from the original on 2021-08-28. Retrieved 2019-09-06.
- ^ Zhu M, Zhao W, Jimenez H, Zhang D, Yeola S, Dai R, et al. (April 2005). "Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes". Drug Metabolism and Disposition. 33 (4): 500–7. doi:10.1124/dmd.104.000836. PMID 15640381. S2CID 10142905.
- ^ a b c d e f g h "Buspirone Hydrochloride Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Archived from the original on 6 March 2019. Retrieved 3 March 2019.
- ^ a b c d Wilson, TK; Tripp, J (January 2018). "Buspirone". StatPearls. PMID 30285372. Archived from the original on 2020-08-11. Retrieved 2019-03-05.
- ^ a b c d e f g British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 338. ISBN 9780857113382.
- ^ "WHOCC - ATC/DDD Index". www.whocc.no. Archived from the original on 7 November 2020. Retrieved 6 September 2020.
- ^ "Buspirone Pregnancy and Breastfeeding Warnings". Drugs.com. Archived from the original on 6 March 2019. Retrieved 3 March 2019.
- ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Archived from the original on 2019-03-06. Retrieved 3 March 2019.
- ^ "The Top 300 of 2020". ClinCalc. Archived from the original on 12 February 2021. Retrieved 11 April 2020.
- ^ "Buspirone - Drug Usage Statistics". ClinCalc. Archived from the original on 8 July 2020. Retrieved 11 April 2020.